The adipocyte-derived hormone leptin maintains energy balance by acting on hypothalamic leptin receptors (Leprs) that act on the signal transducer and activator of transcription 3 (Stat3) [1] [2] [3] [4] . Although disruption of Lepr-Stat3 signaling promotes obesity in mice, other features of Lepr function, such as fertility, seem normal, pointing to the involvement of additional regulators. Here we show that the cyclic AMP responsive element-binding protein-1 (Creb1)-regulated transcription coactivator-1 (Crtc1) is required for energy balance and reproduction-Crtc1 À/À mice are hyperphagic, obese and infertile. Hypothalamic Crtc1 was phosphorylated and inactive in leptin-deficient ob/ob mice, while leptin administration increased amounts of dephosphorylated nuclear Crtc1. Dephosphorylated Crtc1 stimulated expression of the Cartpt and Kiss1 genes, which encode hypothalamic neuropeptides that mediate leptin's effects on satiety and fertility [5] [6] [7] . Crtc1 overexpression in hypothalamic cells increased Cartpt and Kiss1 gene expression, whereas Crtc1 depletion decreased it. Indeed, leptin enhanced Crtc1 activity over the Cartpt and Kiss1 promoters in cells overexpressing Lepr, and these effects were disrupted by expression of a dominant-negative Creb1 polypeptide. As leptin administration increased recruitment of hypothalamic Crtc1 to Cartpt and Kiss1 promoters, our results indicate that the Creb1-Crtc1 pathway mediates the central effects of hormones and nutrients on energy balance and fertility.
The adipocyte-derived hormone leptin maintains energy balance by acting on hypothalamic leptin receptors (Leprs) that act on the signal transducer and activator of transcription 3 (Stat3) [1] [2] [3] [4] . Although disruption of Lepr-Stat3 signaling promotes obesity in mice, other features of Lepr function, such as fertility, seem normal, pointing to the involvement of additional regulators. Here we show that the cyclic AMP responsive element-binding protein-1 (Creb1)-regulated transcription coactivator-1 (Crtc1) is required for energy balance and reproduction-Crtc1 À/À mice are hyperphagic, obese and infertile. Hypothalamic Crtc1 was phosphorylated and inactive in leptin-deficient ob/ob mice, while leptin administration increased amounts of dephosphorylated nuclear Crtc1. Dephosphorylated Crtc1 stimulated expression of the Cartpt and Kiss1 genes, which encode hypothalamic neuropeptides that mediate leptin's effects on satiety and fertility [5] [6] [7] . Crtc1 overexpression in hypothalamic cells increased Cartpt and Kiss1 gene expression, whereas Crtc1 depletion decreased it. Indeed, leptin enhanced Crtc1 activity over the Cartpt and Kiss1 promoters in cells overexpressing Lepr, and these effects were disrupted by expression of a dominant-negative Creb1 polypeptide. As leptin administration increased recruitment of hypothalamic Crtc1 to Cartpt and Kiss1 promoters, our results indicate that the Creb1-Crtc1 pathway mediates the central effects of hormones and nutrients on energy balance and fertility.
Crtcs (also known as transducers of regulated CREB activity, or TORCs) are latent cytoplasmic coactivators that shuttle to the nucleus in response to cyclic AMP (cAMP) and calcium signals 8, 9 . Similar to the ubiquitously expressed Crtc2, Crtc1 contains conserved phosphorylation (Ser151) and ubiquitination (Lys575) sites that modulate nuclear shuttling and protein stability 10, 11 (Fig. 1a) . However, in contrast to Crtc2, Crtc1 messenger RNA and protein are detected primarily in the brain 12 ( Fig. 1a and Supplementary Fig. 1a online) .
Under basal conditions, Crtc1 is highly phosphorylated in mouse hypothalamic GT1-7 cells 13 (Fig. 1b) . Exposure to cAMP or a calcium activator triggers Crtc1 dephosphorylation and nuclear translocation, whereas a phosphorylation-defective S151A-mutant Crtc1 is constitutively nuclear (Supplementary Fig. 1b ). Wild-type CRTC1 potentiates cAMP-responsive element (CRE)-luciferase reporter activity in HEK293T cells exposed to the adenylate cyclase activator forskolin or the calcium ionophore A23187, whereas phosphorylationdefective S151A CRTC1 upregulates CRE-luciferase activity even under basal conditions (Fig. 1b) . The effects of CRTC1 seem to be CREB1 dependent, because coexpression of a dominant-negative CREB1 polypeptide, called A-CREB 14 , disrupts reporter activity in cells exposed to forskolin or A23187 (Fig. 1b) .
We evaluated the biological role of Crtc1 by insertional mutagenesis of the Crtc1 gene with a promoter-less b-galactosidase (b-Geo) gene cassette. By contrast with tissues from control littermates, Crtc1 mRNA and protein were undetectable in Crtc1 -/-mice (Fig. 1c) . Consistent with its regulation by the Crtc1 promoter, b-Geo cassette expression in the central nervous system of Crtc1-mutant mice mirrored that of endogenous Crtc1 protein ( Fig. 1d and Supplementary Fig. 2a,b online) . In addition to other brain regions, Crtc1 expression was prominent in arcuate and ventromedial nuclei of the hypothalamus (Fig. 1d) .
Crtc1 -/-mice were born at the expected mendelian frequency and they were indistinguishable from controls before weaning. Although their linear growth was unimpaired, adult Crtc1 -/-mice were infertile, and no offspring were obtained from Crtc1 -/-males or Crtc1 -/-females mated with wild-type mice (0/6 matings). Crtc1 -/-female uteri appeared threadlike, with noticeable thinning of the endometrium (Fig. 1e) . Although Crtc1 -/-ovaries had comparable numbers of mature follicles to those of wild-type ovaries, they contained no corpora lutea, markers of ovulation (Fig. 1e) . Correspondingly, circulating concentrations of pituitary luteinizing hormone, a key regulator of ovulation, were downregulated in Crtc1-mutant mice (Fig. 1e) .
Male and female Crtc1 -/-mice developed persistent obesity beginning at 9 weeks of age on a normal chow diet, and Crtc1 +/-heterozygotes had intermediate weight gains (Fig. 1f) . White adipose mass was increased two-to threefold in Crtc1-mutant mice, whereas other tissues were unaffected ( Fig. 1f and Supplementary Fig. 3 online). These results indicate that the effects of Crtc1 on body weight are specific to white adipose tissue, affect both males and females and vary with gene dosage.
We performed metabolic studies to determine why Crtc1-mutant mice gain more weight than do wild-type mice. Relative to controls, Crtc1 -/-mice ate more and expended less energy at 12-14 weeks of age, and they became hyperglycemic and hypertriglyceridemic at 9 months of age (Fig. 2a,b) . Pointing to the development of insulin resistance, circulating insulin abundance was increased in Crtc1 +/-mice and was increased to an even greater extent in Crtc1 -/-homozygotes, who we found to be glucose intolerant by intraperitoneal (i.p.) glucose tolerance testing (Fig. 2b,c) . Circulating leptin concentrations were also upregulated in Crtc1 -/-mice (Fig. 2b) .
During feeding, increases in circulating concentrations of leptin as well as insulin and glucose promote satiety and fertility, in part through the activation of arcuate neurons in the hypothalamus 4, [15] [16] [17] . Realizing that Crtc1 -/-mice are hyperphagic, obese and infertile, we wondered whether Crtc1 is required for the activation of relevant hypothalamic programs in response to feeding signals. Although chronic leptin infusion reduced food intake and body weight in control mice, as has been reported before 18 , it had minimal effects on Crtc1 -/-mice (Fig. 2d) . Arguing against potential effects on leptin bioavailability, chronic leptin infusion promoted Stat3 phosphorylation comparably in arcuate neurons of wild-type and Crtc1 -/-mice (Fig. 2e) .
Consistent with the ability of leptin to increase hypothalamic Stat3 activity, mRNA amounts of proopiomelanocortin, neuropeptide Y and agouti-related peptide, regulatory targets of the Lepr-Stat3 pathway, were comparable between Crtc1-mutant mice and controls (Supplementary Fig. 4a,b online) . Signaling through the downstream melanocortin pathway also seemed normal in Crtc1 mutants, because i.p. administration of the a-melanocyte-stimulating hormone analog MTII 19 inhibited food intake similarly in wild-type and Crtc1 -/-mice ( Supplementary Fig. 5 online) .
We used leptin-deficient ob/ob mice to determine whether Crtc1 activity is disrupted by loss of leptin signaling. Supporting this idea, ob/ob mice had increased amounts of phosphorylated, inactive Crtc1 in the hypothalamus compared to wild-type controls (Fig. 2f) . Injection of leptin i.p. increased the amounts of dephosphorylated, nuclear Crtc1 protein in arcuate cells of ob/ob mice (Fig. 2g) . Consistent with a parallel role for nutrient signaling, i.p. glucose administration also promoted the accumulation of dephosphorylated Crtc1 in the hypothalamus ( Supplementary Fig. 6a online) . Correspondingly, Crtc1 localized in the nucleus in arcuate cells during ad libitum feeding but remained cytoplasmic in other central nervous system regions ( Supplementary Fig. 6b ).
We performed gene profiling studies to identify hypothalamic genes that contribute to the metabolic and reproductive phenotypes of Crtc1-mutant mice. This analysis revealed that mRNAs for the neuropeptide genes cocaine and amphetamine-regulated transcript prepropeptide (Cartpt) and Kiss1 were downregulated in Crtc1 À/À mice (data not shown). Cartpt and Kiss1 have been found to mediate effects of Lepr signaling on feeding and fertility 6, 7, 20, 21 . Cartpt is expressed with proopiomelanocortin in arcuate neurons, where it inhibits food intake in response to leptin 21 , whereas arcuate Kiss1 promotes reproductive function by stimulating the secretion of hypothalamic gonadotropin-releasing hormone 22, 23 . Similar to Crtc1 -/-mice, Kiss1-mutant mice have low circulating concentrations of luteinizing hormone, show abnormal uterine morphology and are infertile 24 . We confirmed that the Cartpt and Kiss1 genes are downregulated in Crtc1 -/-mice by quantitative PCR (Q-PCR) and in situ hybridization analysis (Fig. 3a,b) . Hypothalamic staining for kisspeptin, a cleavage product of the Kiss1 precursor, was substantially reduced in Crtc1 -/-arcuate neurons (Fig. 3b) . Notably, Crtc1-driven b-galactosidase mRNA was co-expressed with Cartpt and Kiss1 neuropeptides in arcuate cells (Fig. 3c) .
Realizing that Cartpt 25-27 and Kiss1 (data not shown) promoters contain conserved Creb1 binding sites, we considered that Crtc1 may regulate both genes via a direct mechanism. Supporting this idea, Creb1 has been shown to promote Cartpt gene expression [25] [26] [27] , although its role in Kiss1 regulation has not been established. In keeping with its effects on Crtc1 dephosphorylation, A23187 treatment increased Cartpt and Kiss1 mRNA levels in GT1-7 cells, and this induction was attenuated after depletion of Crtc1 by RNA interference (RNAi)-mediated knockdown (Fig. 3d) . Exposure to A23187 or forskolin also increased Cartpt and KISS1 reporter activities in transient assays (Fig. 4a,b) ; overexpression of wild-type CRTC1 and, to a greater extent, phosphorylation-defective (S151A) CRTC1 enhanced transcription from both promoters in HEK293T cells (Fig. 4a,b) . Consistent with the importance of Creb1, expression of dominant-negative A-CREB inhibitor blocked induction of the KISS1 reporter by forskolin and A23187 in HEK293T cells (Fig. 4b) .
We performed chromatin immunoprecipitation assays (ChIPs) to determine whether Crtc1 and Creb1 regulate Cartpt and Kiss1 genes directly. Creb1 occupied Cartpt and Kiss1 promoters in GT1-7 cells Crtc1 under basal conditions and after exposure to forskolin or A23187 (Fig. 4c) . Crtc1 occupancy of the Cartpt and Kiss1 promoters was low under basal conditions (when Crtc1 is sequestered in the cytoplasm) and increased after exposure to cAMP or calcium activator (when dephosphorylated Crtc1 shuttles to the nucleus and binds Creb1; Supplementary Fig. 1b) . Consistent with its effect on nuclear Crtc1 protein amounts in arcuate neurons, i.p. leptin administration also enhanced recruitment of hypothalamic Crtc1 to Cartpt and Kiss1 promoters in ob/ob mice (Fig. 4d) . Taken together, these results indicate that Creb1 and Crtc1 regulate Cartpt and Kiss1 gene expression through a direct mechanism. On the basis of the importance of Crtc1 and Creb1 for transcriptional induction by cAMP and calcium signals, we wondered whether they are required for the effects of leptin on neuropeptide gene expression. Exposure to leptin increased Cartpt and KISS1 reporter activities synergistically with forskolin in Lepr-expressing HEK293T cells, and these effects were augmented by CRTC1 overexpression (Fig. 4e,f) . Similar to its effects on cAMP and calcium signaling, A-CREB inhibitor blocked induction of the KISS1 promoter in cells treated with leptin (Fig. 4f) .
Our results indicate that Crtc1 is activated by hormonal and nutrient signals in the hypothalamus, where it promotes energy balance and fertility by enhancing Creb1 activity over relevant genes. Like leptin-deficient ob/ob mice, Crtc1 -/-females have abnormal uterine morphology and low circulating luteinizing hormone levels 28 . However, Crtc1-mutant mice are only moderately obese, potentially reflecting compensatory effects of other Crtc family members.
In addition to its effects on Stat3, leptin has also been reported to modulate cation channel activity 29 and inhibit the activity of the AMP-activated kinase 17 . Given the ability of calcium and AMP-activated kinase pathways to regulate Crtc1 activity, we imagine that these pathways may also mediate the stimulatory effects of leptin on Crtc1.
Obesity risk in humans has a strong genetic component, which is thought to involve heterozygous loss-of-function mutations in genes that, individually, may show only modest phenotypic changes. The presence of hyperphagia, increased adiposity and insulin resistance in Crtc1 +/-mice suggests that mutations in the Crtc1 gene may also promote the development of obesity in humans. Future studies of Crtc1 gene mutations in affected populations should provide further insight.
METHODS
Mice. We housed mice in a temperature-controlled environment under a 12-h light-dark cycle with free access to water and a standard rodent chow diet (Lab Diet 5001). We obtained approval for mouse studies from the Salk Institute Institutional Animal Care and Use Committee. We obtained mouse embryonic stem cells containing an insertional gene trap in the Crtc1 gene (XK522; 129/Ola mouse strain) from BayGenomics 30, 31 . We injected embryonic cells into C57BL/6 blastocysts to generate chimeric mice. We backcrossed heterozygous mice with C57BL/6 mice for three generations and then intercrossed them to obtain homozygous Crtc1 -/-mice. We obtained male C57BL/6J, BKS.Cg-m +/+ Leprdb/J and B6.V LepOb mice from Jackson Laboratories.
Genotyping. We prepared genomic DNA from tail biopsies as previously described 32 . We verified insertion of the pGT0lxf cassette by sequence analysis with primers A (5¢-GCATCCCTAGCTCTCACTCAGTTAC-3¢) and B (5¢-GCG CGTACATCGGGCAAATAA-3¢). We genotyped Crtc1-mutant mice by PCR amplification of wild-type and mutant alleles. We amplified the wild-type allele with primers A and C (5¢-ATTCCTCATATACCTCTCTTCTGGTGC-3¢), and we amplified the mutant allele with primers A and D (5¢-GCATGAAT CAACTTTGGAGACATGCG-3¢).
Plasmids and drugs. We generated the KISS1 luciferase reporter by cloning the human KISS1 promoter region spanning -1141 to +8 base pairs from the start of exon 1, into pGL2 (Promega). The EVX-1 luciferase reporter and CRTC1 expression constructs have been previously described 33 . We constructed lentiviruses encoding U6 promoter-driven interfering RNAs directed against the Crtc1 sequence, 5¢-GGTCCCTGCCCAACGTGAAC-3¢, as previously described 34 . We purchased forskolin (Sigma), A23187 (Calbiochem) leptin (R&D Systems) and MTII (Bachem) from the respective manufacturers. We used dimethyl sulfoxide (Sigma) as a diluent and vehicle control for forskolin and A23187. We used sterile PBS as a diluent and vehicle control for leptin and MTII.
Food intake and indirect calorimetry. We housed mice individually for 3 d before measuring food intake or calorimetry. We monitored locomotor activity, oxygen consumption and carbon dioxide production with a Comprehensive Lab Animal Monitoring System (Columbus) 32 . We administered saline, leptin (2 mg g -1 ) and MTII (2 mg g -1 ) by i.p. injection 30 min before the onset of the dark cycle.
Nutrient and hormone measurements. We collected blood from the tail vein into EDTA-coated capillary tubes (StatSpin). We measured blood glucose and triglyceride levels with a OneTouch Ultra glucometer (LifeScan) and a CardioChek PA analyzer. We determined insulin (Mercodia) and leptin (Alpco) abundance according the manufacturers' protocols. We obtained luteinizing hormone levels through the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core. For glucose tolerance testing, we fasted mice for 16 h and then injected them with glucose (2 mg g -1 ; i.p.).
Subcutaneous infusion. We filled osmotic minipumps (0.25 ml h -1 , Alzet) with 0.45-mm-filtered sterile PBS or leptin (1.2 mg ml -1 ) and implanted the primed pumps subcutaneously into isoflurane-anesthetized 7-8-week-old male Crtc1 -/-and wild-type littermates. We measured body weight and food intake daily for 10 d.
Immunohistochemistry and in situ hybridization. We performed immunohistochemistry and in situ hybridization experiments as previously described 35 .
To optimize cellular labeling for Cartpt and Kiss1, we injected mice intracerebroventricularly with 5 ml sterile colchicine (2 mg ml -1 ) as previously described 36 .
Cell culture, transfections and luciferase assays. We cultured GT1-7 cells (a gift from P. Mellon) and HEK293T cells (American Type Culture Collection) in DMEM (Mediatech) containing 10% FBS (HyClone), 100 mg ml -1 penicillinstreptomycin and 1 mM pyruvate (Mediatech). We performed transient transfections of GT1-7 cells with Fugene HD (Roche). We transfected HEK293T cells with Lipofectamine 2000 (Invitrogen). We determined luciferase and b-galactosidase activities as previously described 33 .
RNA isolation and quantitative real-time PCR. We determined mRNA levels by Q-PCR analysis with the LightCycler 480 (Roche) as previously described 10, 11 .
Gene-profiling experiments. We fasted male 12-week-old wild-type and Crtc1 -/-mice (three of each genotype) overnight for 16-18 h and then fed them a normal chow diet for 6 h. We performed gene-profiling experiments on total hypothalamic RNAs with an Affymetrix Mouse Genome 430 array as previously described 37 .
Chromatin immunoprecipitation assays. We plated GT1-7 cells in 15-cm plates and treated them as indicated in Figure 4c . For mouse experiments, we dissected hypothalamic tissue from mice after the indicated manipulations. We prepared chromatin and performed immunoprecipitations as previously described 37 .
Western blots. We performed immunoblots for Crtc1, Crtc2, Creb1 and phosphorylated Creb1 Ser133 as previously described 10, 11 with antibodies 6939E1, 6865, 244 and 5322, respectively (Salk Institute). We obtained antibodies for phosphorylated (Ser151) Crtc1 from Cell Signaling. We used immunoblots for Hsp90 (Santa Cruz Biotechnology) or nonspecific immunoreactive bands as negative controls.
Cell counting. We quantified phosphorylated Stat3 staining as well as nuclear and cytoplasmic Crtc1 staining in hypothalamic sections with an independent observer in a blinded manner. We counted five to eight matched arcuatecontaining sections in whole-brain series from independent experiments.
Statistical analyses. Data presented are means ± s.e.m. We performed statistical analyses with SigmaStat (Systat). We determined statistical differences for one factor between two groups or more than two groups with an unpaired Student's t-test or an analysis of variance (ANOVA) with a post-hoc test, respectively. We determined statistical differences for two factors between more than two groups with a two-way ANOVA with a post-hoc test. We considered values of P o 0.05 to be statistically significant.
Accession codes. Microarray data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus and are accessible through the accession number GSE12209.
